Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology

20

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics announced the expansion of its long-term strategic alliance with Celgene Corporation to include Nimbus’ HPK1 inhibitor program….

 

 

 

http://www.businesswire.com/news/home/20190709005178/en/Nimbus-Therapeutics-Celgene-Expand-Alliance-Immunotherapy-Oncology/

- Advertisement -